As 2026 begins, a slate of high-stakes clinical readouts—from a pivotal study of Novartis’ cardiovascular candidate pelacarsen to a Phase III test of Eli Lilly’s next-gen Alzheimer's drug—are poised ...

After a lengthy downturn, the biotech industry finally gathered momentum in 2025. Key readouts in obesity, infectious disease ...

"I just know that my brain's not right," said Carrie Richardson, 44. "And so, I hate it. I just want it to be normal." At 41, Carrie developed early-onset Alzheimer's disease. The condition is caused ...

Over the past decade, the University of Alabama at Birmingham has become a national leader in clinical trials — studies examining the use of new treatments in people. Every drug, device and other ...

Nature Communications, and Communications Medicine are interested in publishing high-quality clinical research in all areas of medicine. In this call for papers, we invite submissions of papers ...

With populations aging, chronic diseases becoming more prevalent, and global health experts warning of potential pandemics, the need for rapid therapeutic development has reached unprecedented levels.

Allucent has strategically added executives to its C-suite and is deploying artificial intelligence tools to help small and ...

Discover the key trends shaping clinical research in 2026, from patient-centric approaches to empowering site staff and fostering stronger human connections. Clinical research is changing fast, and ...

PreEvnt’s isaac system enters human clinical trials, bringing non-invasive, breath-based glucose monitoring closer to a late ...

In clinical research, participants in trials may or may not be considered “vulnerable.” Historically, vulnerable research participants have included children, incarcerated individuals, patients with ...

Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public health ...